NCT06855576View on ClinicalTrials.gov

Bioequivalence Study of Paracetamol With Oral Single Dose Administration in Healthy Adult Subjects Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

March 5, 2025

Primary Completion Date

April 17, 2025

Study Completion Date

April 17, 2025

Conditions
FeverPain
Interventions
DRUG

Paracetamol ODT

Experimental Paracetamol 500 mg ODT

DRUG

Alvedon film-coated tablet

Marketed Paracetamol 500 mg film-coated tablet

DRUG

Panadol film-coated Tablet

Marketed Paracetamol 500 mg film-coated tablet

Trial Locations (1)

99084

SocraTec R&D GmbH, Erfurt

All Listed Sponsors
lead

HALEON

INDUSTRY

NCT06855576 - Bioequivalence Study of Paracetamol With Oral Single Dose Administration in Healthy Adult Subjects Under Fasting Conditions | Biotech Hunter | Biotech Hunter